AI assistant
Sending…
PAINCHEK LTD — Capital/Financing Update 2016
Oct 17, 2016
65534_rns_2016-10-17_7dbb0206-2528-4087-ad1b-84b4de085277.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Improving the quality of life for people in pain through novel, cost effective pain assessment tools
==> picture [58 x 49] intentionally omitted <==
==> picture [108 x 34] intentionally omitted <==
ePAT Technologies Limited ABN 21 146 035 127 Suite 5, 95 Hay Street Subiaco WA 6008 Phone +61 8 9388 8290
CAPITAL STRUCTURE AND ESCROWED SECURITIES
EPAT Technologies Ltd (formerly MinQuest Limited) ( “the Company” ) advises that re-quotation of the Company’s securities on ASX, it will have the following securities on issue:
Fully paid ordinary shares
| Fully paid ordinary shares | Unrestricted | Restricted | Total |
|---|---|---|---|
| Shares - quoted | 458,728,433 | - | 458,728,433 |
| Shares – escrowed for 24 months from re-quotation | - | 215,694,618 | 215,694,618 |
| Total | 458,728,433 | 215,694,618 | 674,423,051 |
Listed Options
| Listed options | - $0.07875, | 11 | May | 2017 | 41,609,545 | - | 41,609,545 |
|---|---|---|---|---|---|---|---|
| Total | 41,609,545 | - | 41,609,545 |
Unlisted Options
| Unlisted options | Unrestricted | Restricted | Total |
|---|---|---|---|
| Unlisted options - $0.07875, 11 March 2017 | 4,527,487 | - | 4,527,487 |
| Unlisted options - $0.07875, 23 July 2017 | 3,428,572 | - | 3,428,572 |
| Unlisted options - $0.175, 10 August 2018 | 969,575 | 969,575 | |
| Unlisted options - $0.02, 7 October 2019 escrowed | |||
| 12 months to 7 October 2017 | - | 52,500,000 | 52,500,000 |
| Unlisted options - $0.025, 7 October 2019 escrowed | |||
| 24months to 7 October 2018 | - | 45,000,000 | 45,000,000 |
| Total | 8,925,634 | 97,500,000 | 106,425,634 |
PO Box 226, Subiaco WA 6904 | Email: [email protected] | www.epattechnologies.com
More from PAINCHEK LTD
Director's Dealing
2026
May 25
Board/Management Information
2026
May 24
Share Issue/Capital Change
2026
May 21
Capital/Financing Update
2026
May 21
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 13
Share Issue/Capital Change
2026
Mar 26
Capital/Financing Update
2026
Mar 25
Investor Presentation
2026
Mar 23